![Safety and Pharmacokinetics of PSD502 in Healthy Chinese Male and Female Volunteers: Two Randomized, Double-Blind, Placebo-Controlled, Phase I Trials | Clinical Drug Investigation Safety and Pharmacokinetics of PSD502 in Healthy Chinese Male and Female Volunteers: Two Randomized, Double-Blind, Placebo-Controlled, Phase I Trials | Clinical Drug Investigation](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40261-023-01277-4/MediaObjects/40261_2023_1277_Fig2_HTML.png)
Safety and Pharmacokinetics of PSD502 in Healthy Chinese Male and Female Volunteers: Two Randomized, Double-Blind, Placebo-Controlled, Phase I Trials | Clinical Drug Investigation
![PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore - PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore -](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/bd6540cc-a187-46f2-a677-0e8a13f46e5b/bju_8456_f8.gif)
PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore -
![PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore - PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore -](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/71f070fd-afd0-44ac-adf1-cd0eeecc4495/bju_8456_f2.gif)
PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore -
![PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore - PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore -](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/e1fdb187-db88-4256-989b-349ca2e038f0/bju_8456_f4.gif)
PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore -
![PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore - PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore -](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/e16fd7c8-a2d9-4242-a21d-0d9eafd7969d/bju_8456_f5.gif)
PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore -
![PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore - PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore -](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/d6863433-668c-4bfa-aee2-25655f34b821/bju_8456_f6.gif)
PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore -
![Conversations in the operating room: history of the development of a promising new compound for the treatment of premature ejaculation | Semantic Scholar Conversations in the operating room: history of the development of a promising new compound for the treatment of premature ejaculation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/acbcfefb9fd232423e755fa82b240fa9d13f9d64/3-Figure3-1.png)
Conversations in the operating room: history of the development of a promising new compound for the treatment of premature ejaculation | Semantic Scholar
![Improved Ejaculatory Latency, Control and Sexual Satisfaction When PSD502 is Applied Topically in Men with Premature Ejaculation: Results of a Phase III, Double-Blind, Placebo-Controlled Study - ScienceDirect Improved Ejaculatory Latency, Control and Sexual Satisfaction When PSD502 is Applied Topically in Men with Premature Ejaculation: Results of a Phase III, Double-Blind, Placebo-Controlled Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1743609515331611-gr4.jpg)
Improved Ejaculatory Latency, Control and Sexual Satisfaction When PSD502 is Applied Topically in Men with Premature Ejaculation: Results of a Phase III, Double-Blind, Placebo-Controlled Study - ScienceDirect
![Safety and Pharmacokinetics of PSD502 in Healthy Chinese Male and Female Volunteers: Two Randomized, Double-Blind, Placebo-Controlled, Phase I Trials | Clinical Drug Investigation Safety and Pharmacokinetics of PSD502 in Healthy Chinese Male and Female Volunteers: Two Randomized, Double-Blind, Placebo-Controlled, Phase I Trials | Clinical Drug Investigation](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40261-023-01277-4/MediaObjects/40261_2023_1277_Fig3_HTML.png)
Safety and Pharmacokinetics of PSD502 in Healthy Chinese Male and Female Volunteers: Two Randomized, Double-Blind, Placebo-Controlled, Phase I Trials | Clinical Drug Investigation
![gel psd502 funciona? onde comprar? gel psd502 como usar? gel psd 502 para que serve? psd502 é bom? - YouTube gel psd502 funciona? onde comprar? gel psd502 como usar? gel psd 502 para que serve? psd502 é bom? - YouTube](https://i.ytimg.com/vi/cvxLTXfevWg/hqdefault.jpg)
gel psd502 funciona? onde comprar? gel psd502 como usar? gel psd 502 para que serve? psd502 é bom? - YouTube
![Improved Ejaculatory Latency, Control and Sexual Satisfaction When PSD502 is Applied Topically in Men with Premature Ejaculation: Results of a Phase III, Double-Blind, Placebo-Controlled Study - ScienceDirect Improved Ejaculatory Latency, Control and Sexual Satisfaction When PSD502 is Applied Topically in Men with Premature Ejaculation: Results of a Phase III, Double-Blind, Placebo-Controlled Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1743609515331611-gr1.gif)
Improved Ejaculatory Latency, Control and Sexual Satisfaction When PSD502 is Applied Topically in Men with Premature Ejaculation: Results of a Phase III, Double-Blind, Placebo-Controlled Study - ScienceDirect
![PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore - PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled study - Dinsmore -](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/17ef3997-f6a1-4417-8c69-c5c131b42c2b/bju_8456_f7.gif)